Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.
PrivateLast Round
Series D
Extension
Nov 1, 2025
Est. Valuation
$351.61M
Total Funding Raised
$39.31M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Jiangyin. Its latest recorded funding round was a Series D Extension round in November 2025.
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. is a biopharmaceutical company that specializes in the research, development, and production of innovative peptide and chemical drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. Comparables
Compare Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Peptilogics | 79% | |
| Pharma Holdings | 78% | |
| Omnix Medical Ltd. | 77% |
For institutional investors. Book with your work email.
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Nov 1, 2025 | ||||
| Series D | Jan 1, 2023 | ||||
| Series C Extension | Oct 31, 2018 | ||||
| Series C | Jan 1, 2018 | ||||
| Series B | Dec 9, 2016 | ||||
Series A | Feb 29, 2016 |
For institutional investors. Book with your work email.
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yinxinggu Capital | Series B |
| Huajin Capital | Series D |
| SDIC Venture Capital | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
Open roles increased to 11, 367% of current headcount.
- Nov 1, 2025
Raised $32M in a Series D Extension round.
For institutional investors. Book with your work email.
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. a public or private company?
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. is a private company.
What is the current stock price of Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.?
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. worth (valuation)?
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.'s valuation is estimated at $351.6M based on funding round data.
Can I buy Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. stock?
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.'s last funding round?
Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.'s most recent funding round was Series D Extension on November 1, 2025.
Who are the main investors in Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.?
Key investors in Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. include Yinxinggu Capital, Huajin Capital, SDIC Venture Capital.
Will Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd..
How can I track Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.'s shares on secondary markets.